JANE STREET GROUP, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,077 filers reported holding NOVARTIS A G in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$18,006,810
+49.7%
176,780
+48.3%
0.01%
+50.0%
Q2 2023$12,029,783
-48.0%
119,213
-52.6%
0.00%
-55.6%
Q1 2023$23,144,072
-45.3%
251,566
-46.1%
0.01%
-55.0%
Q4 2022$42,328,773
+88.1%
466,587
+57.6%
0.02%
+100.0%
Q3 2022$22,508,000
-25.7%
296,121
-17.4%
0.01%
-23.1%
Q2 2022$30,303,000
-56.6%
358,494
-55.0%
0.01%
-40.9%
Q1 2022$69,830,000
+47.8%
795,775
+47.3%
0.02%
+46.7%
Q4 2021$47,254,000
+23.4%
540,230
+15.4%
0.02%
+7.1%
Q3 2021$38,281,000
+2.5%
468,105
+14.3%
0.01%0.0%
Q2 2021$37,360,000
+19.1%
409,480
+11.6%
0.01%
-12.5%
Q1 2021$31,359,000
-39.7%
366,850
-33.4%
0.02%
-38.5%
Q4 2020$51,976,000
+19.0%
550,415
+9.5%
0.03%0.0%
Q3 2020$43,695,000
+31.3%
502,463
+31.9%
0.03%0.0%
Q2 2020$33,269,000
+112.1%
380,903
+100.2%
0.03%
+62.5%
Q1 2020$15,684,000
+19.1%
190,215
+36.7%
0.02%
-15.8%
Q4 2019$13,172,000
-29.5%
139,097
-35.3%
0.02%
-38.7%
Q3 2019$18,684,000
-40.4%
215,005
-37.3%
0.03%
-44.6%
Q2 2019$31,335,000
+286.3%
343,159
+306.7%
0.06%
+330.8%
Q1 2019$8,112,000
-28.7%
84,374
-36.4%
0.01%
-45.8%
Q4 2018$11,381,000
+156.3%
132,617
+157.3%
0.02%
+166.7%
Q3 2018$4,441,000
-68.0%
51,546
-71.9%
0.01%
-71.9%
Q2 2018$13,861,000
+304.3%
183,490
+332.8%
0.03%
+300.0%
Q1 2018$3,428,000
-77.2%
42,393
-76.4%
0.01%
-81.4%
Q4 2017$15,061,000
-8.8%
179,380
-6.7%
0.04%
-20.4%
Q3 2017$16,511,000
+52.6%
192,319
+48.4%
0.05%
+42.1%
Q2 2017$10,819,000
+268.9%
129,608
+228.2%
0.04%
+192.3%
Q1 2017$2,933,000
-18.7%
39,495
-20.3%
0.01%
-18.8%
Q4 2016$3,609,000
-41.6%
49,551
-36.7%
0.02%
-46.7%
Q3 2016$6,182,000
+585.4%
78,300
+616.6%
0.03%
+500.0%
Q2 2016$902,000
-94.3%
10,927
-95.0%
0.01%
-94.4%
Q1 2016$15,918,000
+5.4%
219,752
+25.2%
0.09%
-5.3%
Q4 2015$15,104,000
-71.7%
175,541
-69.8%
0.09%
-71.9%
Q3 2015$53,364,000
+7426.7%
580,549
+7948.6%
0.33%
+6580.0%
Q2 2015$709,000
-85.9%
7,213
-85.9%
0.01%
-87.2%
Q1 2015$5,044,000
-28.7%
51,148
-38.5%
0.04%
-50.0%
Q1 2014$7,072,00083,1820.08%
Other shareholders
NOVARTIS A G shareholders Q3 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders